Methods and pharmaceutical compositions for the treatment of cancers associated with activation of the mapk pathway
US-2019365920-A1 · Dec 5, 2019 · US
This page is not indexed by search engines while we improve data quality.
Ct Hospitalier Universitaire Toulouse patents in 2019
Ct Hospitalier Universitaire Toulouse was listed as an assignee on 10 patent publications in 2019.
| Metric | Value |
|---|---|
| Company | Ct Hospitalier Universitaire Toulouse |
| Year | 2019 |
| Patents | 10 |
Patents
Representative publications for Ct Hospitalier Universitaire Toulouse in 2019.
Method and pharmaceutical composition for use in the treatment of diabetes
US-10426818-B2 · Oct 1, 2019 · US
Inhibition of chemokine CCL7 or receptor CCR3 of same for the treatment and diagnosis of prostate cancer
US-10401365-B2 · Sep 3, 2019 · US
Pharmaceutical compositions for the treatment of chemoresistant acute myeloid leukemia (aml)
US-2019209594-A1 · Jul 11, 2019 · US
Anti-hla monoclonal chimeric immunoglobulin, process and kit employing such a monoclonal chimeric immunoglobulin
US-2019135924-A1 · May 9, 2019 · US
Top CPC classifications
Most common classification codes for Ct Hospitalier Universitaire Toulouse in 2019.
| CPC | Patents |
|---|---|
| A61P35/00 | 7 |
| A61K45/06 | 5 |
| C07K16/2818 | 3 |
| A61K2039/505 | 2 |
| A61K2039/507 | 2 |
Related pages
Navigate to parent entity pages.